OAM
Origin Asset Management Portfolio holdings
AUM
$43.5M
This Quarter Return
-6.81%
1 Year Return
+31.63%
3 Year Return
+59.29%
5 Year Return
+154.07%
10 Year Return
+689.26%
AUM
$1.21B
AUM Growth
+$1.21B
(-12%)
Cap. Flow
-$47.1M
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
32.32%
Holding
123
New
22
Increased
12
Reduced
47
Closed
24
Top Buys
| 1 |
Dr. Reddy's Laboratories
RDY
|
$38.2M |
| 2 |
Cognizant
CTSH
|
$30.5M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$18M |
| 4 |
Universal Health Services
UHS
|
$15M |
| 5 |
Meta Platforms (Facebook)
META
|
$14M |
Top Sells
| 1 |
Biogen
BIIB
|
$32.5M |
| 2 |
Lincoln National
LNC
|
$21M |
| 3 |
TSMC
TSM
|
$19.7M |
| 4 |
Blackrock
BLK
|
$15.2M |
| 5 |
TTM
Tata Motors Limited
TTM
|
$14.4M |
Sector Composition
| 1 | Technology | 24.69% |
| 2 | Healthcare | 20.85% |
| 3 | Financials | 15.03% |
| 4 | Industrials | 12.24% |
| 5 | Consumer Discretionary | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Cognizant
CTSH
$35.3B
| $62M | 5.14% | 990,422 +487,475 | +97% | +$30.5M |
|
2
NetEase
NTES
$86.2B
| $49.7M | 4.11% | 413,341 -67,685 | -14% | -$8.13M |
|
|
3
TSMC
TSM
$1.2T
| $46.9M | 3.89% | 2,261,580 -949,300 | -30% | -$19.7M |
|
4
Apple
AAPL
$3.45T
| $43.3M | 3.59% | 392,307 +21,829 | +6% | +$2.41M |
|
|
5
Dr. Reddy's Laboratories
RDY
$11.8B
| $38.2M | 3.16% | +597,468 | New | +$38.2M |
|
6
Lear
LEA
$5.85B
| $34M | 2.82% | 312,727 +23,696 | +8% | +$2.58M |
|
7
Snap-on
SNA
$17B
| $31M | 2.57% | 205,104 -7,109 | -3% | -$1.07M |
|
8
Foot Locker
FL
$2.36B
| $29.1M | 2.41% | 404,644 -62,656 | -13% | -$4.51M |
|
9
Gilead Sciences
GILD
$140B
| $28.6M | 2.37% | 291,542 -12,887 | -4% | -$1.27M |
|
10
General Dynamics
GD
$87.3B
| $27.3M | 2.26% | 197,594 +52,172 | +36% | +$7.2M |
|
11
Marathon Petroleum
MPC
$54.6B
| $25.6M | 2.12% | 553,016 +149,116 | +37% | +$6.91M |
|
12
Goldman Sachs
GS
$226B
| $25.4M | 2.11% | 146,350 -24,849 | -15% | -$4.32M |
|
|
AET
13
DELISTED
Aetna Inc
AET
| $25.2M | 2.09% | 230,466 -39,161 | -15% | -$4.28M |
|
14
Cigna
CI
$80.3B
| $24.9M | 2.07% | 184,674 -95,444 | -34% | -$12.9M |
|
|
CELG
15
DELISTED
Celgene Corp
CELG
| $22.1M | 1.83% | 204,339 -9,498 | -4% | -$1.03M |
|
16
HCA Healthcare
HCA
$94.5B
| $21.1M | 1.75% | 272,708 +162,471 | +147% | +$12.6M |
|
17
CVS Health
CVS
$92.8B
| $20.9M | 1.73% | 216,518 -5,989 | -3% | -$578K |
|
18
Jones Lang LaSalle
JLL
$14.5B
| $20.8M | 1.73% | 144,896 +1,016 | +0.7% | +$146K |
|
19
Moody's
MCO
$91.4B
| $20.5M | 1.7% | 208,457 -8,180 | -4% | -$803K |
|
20
Wells Fargo
WFC
$263B
| $20.1M | 1.66% | 390,803 -13,630 | -3% | -$700K |
|
21
Aon
AON
$79.1B
| $18.6M | 1.54% | 210,189 -6,640 | -3% | -$588K |
|
|
22
Regeneron Pharmaceuticals
REGN
$61.5B
| $18M | 1.49% | +38,775 | New | +$18M |
|
23
Broadcom
AVGO
$1.4T
| $16.5M | 1.37% | 131,998 -4,688 | -3% | -$586K |
|
24
Valero Energy
VLO
$47.2B
| $15.8M | 1.31% | 263,285 +178,647 | +211% | +$10.7M |
|
25
F5
FFIV
$18B
| $15.7M | 1.3% | 135,461 -8,536 | -6% | -$988K |
|